TY  - RPRT
TI  - The likelihood of heterogeneity or additional mutation in KRAS or associated oncogenes to compromise targeting of oncogenic KRAS G12C
AU  - Cannataro, V. L.
AU  - Gaffney, S. G.
AU  - Stender, C.
AU  - Zhao, Z.-M.
AU  - Philips, M.
AU  - Greenstein, A.
AU  - Townsend, J. P.
PY  - 2017
DO  - 10.1101/149724
UR  - https://www.biorxiv.org/content/10.1101/149724v1
ID  - 10.1101/149724
ER  -